IV ZMA001 study in healthy adults
Part of Lungs & breathing clinical trials.
This Phase 1 trial tests how an IV medicine called ZMA001 behaves in healthy people and checks for early safety. It may help future studies of the drug by confirming dosing and effects in people before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be willing to follow all study instructions and stay for the full study
- Be 18 to 60 years old and generally healthy based on your medical history
- If you can become pregnant, use reliable birth control during the study and for 120 days after the IV dose
- If you are a sexually active man with a female partner, use condoms with spermicide for 120 days after the dose (or have had the right sterilization timing) and do not donate sperm for 120 days
- Be able to understand the study and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This study tests a new investigational drug called JZP047 in healthy volunteers. Researchers want to see how safe it is, how the body processes it, and whether taking it with food changes its effects.
This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.
This study is testing a new medicine called ZE66-0205 for the first time in people. It is looking at healthy volunteers to see how the drug is processed by the body and if it is safe.
This early-phase study tests whether ZB002 is safe in people, and how the body handles the drug. It includes both healthy volunteers and people with rheumatoid arthritis (RA) to see if the drug has a predictable blood level pattern.
Hear when a new Pulmonary Arterial Hypertension PAH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.